Form 4: Procept BioRobotics EVP Alaleh Nouri Sells Shares Under 10b5-1 Plan

Alaleh Nouri, EVP, CLO, and Corporate Secretary of Procept BioRobotics Corp, sold shares of common stock on June 17, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Alaleh Nouri, an executive at Procept BioRobotics Corp, reported the sale of company stock on June 17, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on March 13, 2024.
• A total of 8,952 shares were sold at a weighted average price of $62.0449, with individual prices ranging from $61.64 to $62.62.
• An additional 1,048 shares were sold at a weighted average price of $63.2996, with individual prices ranging from $62.66 to $63.44.
• Following these transactions, Nouri directly owns 52,472 shares of Procept BioRobotics Corp.
• The transactions were reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-existing 10b5-1 plan. There's no indication of positive or negative sentiment towards the company's prospects.

Industry Context

Executive stock sales are a common occurrence, and sales under 10b5-1 plans are often viewed as less impactful since they are pre-planned. However, investors may still analyze the transactions for insights into executive sentiment.

Stakeholder Impact

• Shareholders may be interested in the executive's stock sales, although sales under 10b5-1 plans are generally less concerning.

Key Dates